Do you ever experience periods of muscle weakness, loss of muscle strength or limp muscles in any part of your body, such as the legs or face, when you hear or tell a joke [PhenX] 65624-9
LOINC Code
LOINC code | 65624-9 | ||
---|---|---|---|
name | Do you ever experience periods of muscle weakness, loss of muscle strength or limp muscles in any part of your body, such as the legs or face, when you hear or tell a joke [PhenX] | ||
status | TRIAL | ||
Fully-Specified Name | |||
component | Do you ever experience periods of muscle weakness, loss of muscle strength or limp muscles in any part of your body, such as the legs or face, when you hear or tell a joke | ||
property | Find = Finding | ||
time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||
system | ^Patient | ||
scale | Ord = Ordinal: Ordered categorical responses, e.g., 1+, 2+, 3+; positive, negative; reactive, indeterminate, nonreactive. | ||
method | PhenX | ||
Additional Names | |||
short name | Muscle weakness joke PhenX | ||
Basic Attributes | |||
class | PHENX | ||
type | 2 Clinical | ||
Associated Observations | |||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||
Member of these Panels | |||
| |||
History/Usage | |||
first released | |||
last updated | 2.65 | ||
last change type | MIN - change to field other than name | ||
change reason | Updated the PhenX ID from "PhenX. | ||
Related Names | |||
|
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.